These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
90 related articles for article (PubMed ID: 6828287)
1. Ferritin as a chronobiological marker in immunoproliferative diseases. Neri B; Comparini T; Guidi S; Pieri A; Tommasi M Oncology; 1983; 40(2):111-4. PubMed ID: 6828287 [No Abstract] [Full Text] [Related]
2. Radioimmunoassay of serum ferritin in patients with malignancy. Niitsu Y; Kogo Y; Yokota M; Urushizaki I Ann N Y Acad Sci; 1975 Aug; 259():450-2. PubMed ID: 1060427 [No Abstract] [Full Text] [Related]
3. [Light-chain myeloma and non-secretory myeloma--problems in di- agnosis and associated paraproteins]. Leinonen P; Somer T Duodecim; 1988; 104(18):1466-70. PubMed ID: 3141128 [No Abstract] [Full Text] [Related]
4. [IgM myeloma. Report of 2 cases]. Pamies Andreu E; Sánchez Román J; Noguer Mediavilla M; Arca Sosa V Rev Clin Esp; 1986 Oct; 179(6):305-7. PubMed ID: 3099344 [No Abstract] [Full Text] [Related]
5. [Analysis of parameters discriminating between stage I myelomas and essential monoclonal gammapathies]. Ortega F; San Miguel JF; Hernández JM Med Clin (Barc); 1986 Feb; 86(7):273-6. PubMed ID: 3713342 [No Abstract] [Full Text] [Related]
6. [So-called benign essential monoclonal gammapathy and immunocytoproliferative diseases. Considerations on the problem and case reports]. Fernandes D; Sportiello V; Pace M; Stefan C G Batteriol Virol Immunol; 1981; 74(1-6):163-80. PubMed ID: 6171470 [No Abstract] [Full Text] [Related]